To investigate the effect of the C5a–C5aR1 axis on fibrosis, we used a WD and CCl4 treatment for 12 weeks to induce NASH model, because this model results in a rapid progression to severe NASH with fibrosis. The gene discussed is C5AR1; the disease is metabolic dysfunction-associated steatohepatitis.